<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Wahlgren, Nils</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Initial Clinical Results with TREVO® Mechanical Thrombectomy Device are Promising</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">15-16</style></pages><abstract><style  face="normal" font="default" size="100%">Experimental data suggest that the novel Trevo device is highly effective at achieving immediate reperfusion of occluded arteries without causing any clinically significant disruption of vascular integrity [Nogueira RG et al. J Neurointerv Surg 2011]. This article also reports on the promising findings from the Phase 4 Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke trial [TREVO; NCT01088672].</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>